24-hour arterial stiffness monitoring values in patients with COPD

N. Karoli, G. Dolishnyaya, A. Rebrov (Saratov, Russian Federation)

Source: Annual Congress 2013 –COPD: acute exacerbations and others
Session: COPD: acute exacerbations and others
Session type: Poster Discussion
Number: 1867
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Karoli, G. Dolishnyaya, A. Rebrov (Saratov, Russian Federation). 24-hour arterial stiffness monitoring values in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 1867

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015



The use of ambulatory blood pressure monitoring in patients with bronchial asthma and hypertension
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Study assoicção between severity stages of chronic obstructive pulmonary disease and fasting glucose in patients with this disease
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013

24-hour blood pressure monitoring and 10 years systemic coronary risk evaluation in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013


Should all chronic obstructive pulmonary disease (COPD) patients with cardiac co-morbidities have ambulatory oxygen assessment?
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008

Pulse wave velocity in patients with COPD comorbid with arterial hypertension
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008

Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Association between arterial stiffness and acute exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016

Red blood cell distribution with in patients With chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Decreased fractal dimension of heart rate dynamics in patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006